These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10443548

  • 1. Acetylcholinesterase activity of skeletal muscle in a non-immunogenic model for myasthenia gravis in rats.
    Van Kempen GT, Trip SA, Molenaar PC.
    J Neural Transm (Vienna); 1999; 106(5-6):423-31. PubMed ID: 10443548
    [Abstract] [Full Text] [Related]

  • 2. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC, Oen BS, Plomp JJ, Van Kempen GT, Jennekens FG, Hesselmans LF.
    Eur J Pharmacol; 1991 Apr 10; 196(1):93-101. PubMed ID: 1874282
    [Abstract] [Full Text] [Related]

  • 3. Changes in acetylcholinesterase in experimental autoimmune myasthenia gravis and in response to treatment with a specific antisense.
    Blotnick E, Hamra-Amitai Y, Wald C, Brenner T, Anglister L.
    Eur J Neurosci; 2012 Oct 10; 36(8):3077-85. PubMed ID: 22805122
    [Abstract] [Full Text] [Related]

  • 4. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ, Van Kempen GT, De Baets MB, Graus YM, Kuks JB, Molenaar PC.
    Ann Neurol; 1995 May 10; 37(5):627-36. PubMed ID: 7755358
    [Abstract] [Full Text] [Related]

  • 5. Congruity of acetylcholine receptor, acetylcholinesterase, and Dolichos biflorus lectin binding glycoprotein in postsynaptic-like sarcolemmal specializations in noninnervated regenerating rat muscles.
    Crne-Finderle N, Sketelj J.
    J Neurosci Res; 1993 Jan 10; 34(1):67-78. PubMed ID: 8423637
    [Abstract] [Full Text] [Related]

  • 6. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
    Tiedt TN, Albuquerque EX, Hudson CS, Rash JE.
    J Pharmacol Exp Ther; 1978 May 10; 205(2):326-39. PubMed ID: 205647
    [Abstract] [Full Text] [Related]

  • 7. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB, Appel SH.
    Ann Neurol; 1978 Sep 10; 4(3):250-2. PubMed ID: 718136
    [Abstract] [Full Text] [Related]

  • 8. Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor.
    Engel AG, Nagel A, Walls TJ, Harper CM, Waisburg HA.
    Muscle Nerve; 1993 Dec 10; 16(12):1284-92. PubMed ID: 8232383
    [Abstract] [Full Text] [Related]

  • 9. Content and release of acetylcholinesterase in skeletal muscle of rats with experimental autoimmune myasthenia gravis.
    Carter J, Lennon VA, Schreiber P, Brimijoin S.
    Exp Neurol; 1982 Feb 10; 75(2):490-500. PubMed ID: 6980793
    [No Abstract] [Full Text] [Related]

  • 10. Denervation-related changes in acetylcholine receptor density and distribution in the rat flexor digitorum sublimis muscle.
    Guzzini M, Raffa S, Geuna S, Nicolino S, Torrisi MR, Tos P, Battiston B, Grassi F, Ferretti A.
    Ital J Anat Embryol; 2008 Feb 10; 113(4):209-16. PubMed ID: 19507461
    [Abstract] [Full Text] [Related]

  • 11. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME.
    Fed Proc; 1978 Dec 10; 37(14):2823-7. PubMed ID: 720635
    [Abstract] [Full Text] [Related]

  • 12. Effect of diazepam on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC, Van Kempen GT.
    J Neural Transm Gen Sect; 1993 Dec 10; 93(3):181-5. PubMed ID: 8217057
    [Abstract] [Full Text] [Related]

  • 13. Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats.
    Plomp JJ, van Kempen GT, Molenaar PC.
    J Physiol; 1992 Dec 10; 458():487-99. PubMed ID: 1302275
    [Abstract] [Full Text] [Related]

  • 14. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
    Reiness CG, Weinberg CB, Hall ZW.
    Nature; 1978 Jul 06; 274(5666):68-70. PubMed ID: 661996
    [No Abstract] [Full Text] [Related]

  • 15. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG, Lambert EH, Gomez MR.
    Ann Neurol; 1977 Apr 06; 1(4):315-30. PubMed ID: 214017
    [Abstract] [Full Text] [Related]

  • 16. Influence of denervation on the molecular forms of junctional and extrajunctional acetylcholinesterase in fast and slow muscles of the rat.
    Sketelj J, Crne-Finderle N, Brzin M.
    Neurochem Int; 1992 Oct 06; 21(3):415-21. PubMed ID: 1303166
    [Abstract] [Full Text] [Related]

  • 17. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis.
    Brenner T, Hamra-Amitay Y, Evron T, Boneva N, Seidman S, Soreq H.
    FASEB J; 2003 Feb 06; 17(2):214-22. PubMed ID: 12554700
    [Abstract] [Full Text] [Related]

  • 18. Activity-dependent vs. neurotrophic modulation of acetylcholine receptor expression: Evidence from rat soleus and extensor digitorum longus muscles confirms the exclusive role of activity.
    Buffelli M, Tognana E, Cangiano A, Busetto G.
    Eur J Neurosci; 2018 Jun 06; 47(12):1474-1481. PubMed ID: 29904972
    [Abstract] [Full Text] [Related]

  • 19. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J, Wray DW, Pizzighella S, Hall Z, Vincent A.
    Muscle Nerve; 1990 May 06; 13(5):407-13. PubMed ID: 2345558
    [Abstract] [Full Text] [Related]

  • 20. Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC, Biewenga JE, Van Kempen GT, De Priester JA.
    Neuropharmacology; 1993 Apr 06; 32(4):373-6. PubMed ID: 8497338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.